HIV drug resistance tendencies in latvia

Central European Journal of Public Health

Volumn 16, Issue 3, 2008, Pages 138-140

  Kolupajeva, Tatjana ^a   Aldins, Pauls ^a   Guseva, Ludmila ^a   Dusacka, Diana ^a   Sondore, Valentina ^a,c   Viksna, Ludmila ^b   Rozentale, Baiba ^a  

^a State Agency Infectology Center of Latvia   (Latvia)

^b RIGA STRADINS UNIVERSITY   (Latvia)

^c NONE   (Latvia)

Author keywords

Drug resistance; Genotyping; HAART; HIV infection; Mutations

Indexed keywords

EID: 53749092702     PISSN: 12107778     EISSN: None     Source Type: Journal    
DOI: 10.21101/cejph.a3473     Document Type: Article

References (7)

1. Mascolini M, Schapiro J. Clinical implications of resistance to new antiretrovirals: key data from the fourth European HIV drug resistance workshop. Rev Antivir Ther. 2006;2:4-14.
2. Sagir A, Oette M, Kaiser R, Däumer M, Fätkenheuer G, Rockstroh JK, et al. Trends of prevalence of primary HIV drug resistance in Germany. J Antimicrob Chemother. 2007 Oct;60(4):843-8.
3. Johnson VA, Brun-Vézinet F, Clotet B, Günthard HF, Kuritzkes DR, Pillay D, et al. Update of the drug resistance mutations in HIV-1: 2007. Top HIV Med. 2007 Aug-Sep;15(4):119-25.
4. Shafer RW, Rhee SY, Pillay D, Miller V, Sandstrom P, Schapiro JM, et al. HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance. AIDS. 2007 Jan 11;21(2):215-23.
5. Bocharov G, Ford NJ, Edwards J, Breinig T, Wain-Hobson S, Meyerhans A. A genetic-algorithm approach to simulating human immunodeficiency virus evolution reveals the strong impact of multiply infected cells and recombination. J Gen Virol. 2005 Nov;86(Pt 11):3109-18.
6. Chen R, Yokoyama M, Sato H, Reilly C, Mansky LM. Human immunodeficiency virus mutagenesis during antiviral therapy: impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies. J Virol. 2005 Sep;79(18): 12045-57.
7. Jewell NA, Chen R, Raices R, Mansky LM. Nucleoside reverse transcriptase inhibitors and HIV mutagenesis. J Antimicrob Chemother. 2003 Oct;52(4):547-50.